Rajesh Singh

Title: Innovations of Rajesh Singh in Antibody Development

Introduction

Rajesh Singh is an accomplished inventor based in Malvern, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work focuses on creating antibodies that can function effectively in specific pH environments, which has important implications for therapeutic applications.

Latest Patents

Rajesh Singh holds a patent for "Antibodies binding to human CD3 at acidic pH." This invention relates to new anti-hCD3 antibodies that specifically bind to human CD3 at acidic pH, while showing minimal binding at neutral or physiological pH. The ability of these antibodies to activate T cells at acidic pH, combined with their reduced activity at neutral pH, presents a novel approach to immunotherapy.

Career Highlights

Rajesh Singh is currently associated with Abzyme Therapeutics LLC, where he continues to advance his research in antibody development. His work has the potential to lead to new therapeutic strategies for various diseases, particularly those involving immune response modulation.

Collaborations

Rajesh collaborates with talented professionals in his field, including Hiep Tran and Carla Campbell. Their combined expertise enhances the innovative environment at Abzyme Therapeutics LLC.

Conclusion

Rajesh Singh's contributions to antibody research exemplify the impact of targeted innovations in biotechnology. His work not only advances scientific understanding but also holds promise for future therapeutic applications.